Clinical Trial Update: The Influence of IgY Max on Inflammatory Markers and the Gut Microbiome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating IgY Max on inflammatory markers and gut microbiome in healthy individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• IgY Max

Snippet

Sponsor: Igy Nutrition, LLC | Conditions: Healthy | Phase 1, Phase 2 | Status: COMPLETED